Pharmacokinetics and ventilatory effects of oxycodone before and after liver transplantation

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Clinical pharmacology and therapy

• Publication date

  1997-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0009-9236(97)90100-4PMID 9209248
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pharmacokinetic‐pharmacodynamic relationships of controlled‐release oxycodone

  1996cited by this paper
• The pharmacokinetics of oxycodone in uremic patients undergoing renal transplantation.

  1996cited by this paper
• Liposolubility and protein binding of oxycodone in vitro.

  1994cited by this paper
• Inhibition by fluoxetine of cytochrome P450 2D6 activity

  1993cited by this paper
• Liver disease and drug disposition.

  1992cited by this paper
• Comparative Oxycodone Pharmacokinetics in Humans After Intravenous, Oral, and Rectal Administration

  1992cited by this paper
• Effects of different hepatic pathologies on disposition of alfentanil in anaesthetized patients.

  1992cited by this paper
• The pharmacokinetics and metabolism of oxycodone after intramuscular and oral administration to healthy subjects.

  1992cited by this paper
• Is glucuronidation truly preserved in patients with liver disease?

  1991cited by this paper
• The pharmacokinetics of oxycodone after intravenous injection in adults.

  1991cited by this paper
• Intravenous morphine and oxycodone for pain after abdominal surgery

  1991cited by this paper
• Morphine and oxycodone in the management of cancer pain: plasma levels determined by chemical and radioreceptor assays.

  1990cited by this paper
• Morphine and metabolite behavior after different routes of morphine administration: Demonstration of the importance of the active metabolite morphine‐6‐glucuronide

  1990cited by this paper
• The bioavailability and pharmacokinetics of morphine after intravenous, oral and buccal administration in healthy volunteers.

  1989cited by this paper
• Quantitative structure-activity studies on effects of sixteen different steroids on growth and monooxygenases of rat liver.

  1988cited by this paper
• A comparison of the effect of timegadine, levamisole, and D-penicillamine on human neutrophil metabolism of endogenous arachidonic acid and chemotaxis.

  1988cited by this paper
• Isoflurane Causes Regional Myocardial Dysfunction in Dogs with Critical Coronary Artery Stenoses

  1987cited by this paper
• Pharmacokinetics of Unchanged Morphine in Normal and Cirrhotic Subjects

  1987cited by this paper
• Prognostic value of the aminopyrine breath test in cirrhotic patients

  1986cited by this paper
• Do Beta Blockers Differ in Their Effects on Hepatic Microsomal Enzymes and Liver Blood Flow?

  1984cited by this paper
• Determination of oxycodone metabolites in urines and feces of several mammalian species.

  1982cited by this paper
• Normal metabolism of morphine in cirrhosis.

  1981cited by this paper
• Determination of oxycodone in plasma and identification of a major metabolite.

  1979cited by this paper
• Determination of Oxycodone and a Major Metabolite in Urine by Electron-Capture GLC

  1978cited by this paper

• Extended-release and long-acting opioids for chronic pain management.

  2023cites this paper
• Identifying risk factors for opioid-induced neurotoxicity in cancer patients receiving oxycodone

  2023cites this paper
• City, University of London Institutional Repository

  2022cites this paper
• 2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma

  2022cites this paper
• 2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma

  2022cites this paper
• 2022 KLCA-NCC Korea Practice Guidelines for the Management of Hepatocellular Carcinoma

  2022cites this paper
• Pharmacogenomics of oxycodone: a narrative literature review.

  2021cites this paper
• Palliative Care and Cancer Pain

  2021cites this paper
• Pharmacokinetics of Dexmedetomidine in Infants and Children After Orthotopic Liver Transplantation.

  2020cites this paper
• Tapering opioids: a comprehensive qualitative review.

  2020cites this paper
• Prescribing in chronic severe hepatic impairment.

  2019cites this paper
• Updated Clinical Pharmacokinetics and Pharmacodynamics of Oxycodone

  2019cites this paper
• Recommendations for safe medication use in liver impairment: importance of transparency and reflections on analgesics, hypnotics and anti-emetics.

  2019cites this paper
• Medication safety in patients with cirrhosis

  2019cites this paper
• 2018 Korean Liver Cancer Association–National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma

  2019cites this paper
• 2018 Korean Liver Cancer Association–National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma

  2019cites this paper
• PharmGKB summary: oxycodone pathway, pharmacokinetics

  2018cites this paper
• Integrating Palliative Principles into Cirrhosis Care: The Effect of Hepatic Encephalopathy

  2018cites this paper
• Population pharmacokinetics and analgesic potency of oxycodone

  2017cites this paper
• Palliative Care in Liver Transplantation: When to Consult a Specialist

  2017cites this paper
• General Anesthesia for the Patient with End-Stage Liver Disease and Post Liver Transplantation

  2017cites this paper
• Pharmacokinetic and pharmacodynamic evaluation of oxycodone and naltrexone for the treatment of chronic lower back pain

  2016cites this paper
• Perspectives on Intravenous Oxycodone for Control of Postoperative Pain

  2016cites this paper
• Variations of pharmacokinetics of drugs in patients with cirrhosis

  2016cites this paper
• Relationships between oxycodone pharmacokinetics, central symptoms, and serum interleukin-6 in cachectic cancer patients

  2016cites this paper
• Pharmacological Management of Cancer-Related Pain.

  2015cites this paper
• Metabolism and Disposition of Prescription Opioids: A Review.

  2015cites this paper
• 2014 KLCSG-NCC Korea Practice Guideline for the Management of Hepatocellular Carcinoma

  2015cites this paper
• 2014 Korean Liver Cancer Study Group-National Cancer Center Korea Practice Guideline for the Management of Hepatocellular Carcinoma

  2015cites this paper
• Analgesic considerations for liver transplantation patients.

  2015cites this paper
• Oxycodone Frequently Induced Nausea and Vomiting in Oxycodone-Naïve Patients with Hepatic Dysfunction

  2015cites this paper
• Liver Disease and Liver Transplantation

  2015cites this paper
• Pain Management in Patients with Hepatic Impairment

  2015cites this paper
• A Prediction Model of Drug Exposure in Cirrhotic Patients According to Child–Pugh Classification

  2015cites this paper
• Analgesia for the cirrhotic patient: A literature review and recommendations

  2014cites this paper
• Should the dosage of controlled-release oxycodone in advanced cancer be modified on the basis of patient characteristics?

  2014cites this paper
• The Therapeutic Use of Analgesics in Patients With Liver Cirrhosis: A Literature Review and Evidence-Based Recommendations

  2014cites this paper
• Pharmacokinetics of oxycodone hydrochloride and three of its metabolites after intravenous administration in Chinese patients with pain

  2014cites this paper
• End stage liver disease

  2013cites this paper
• Utilisation des analgésiques dans l’insuffisance hépatique

  2013cites this paper
• Cancer Cachexia Raises the Plasma Concentration of Oxymorphone Through the Reduction of CYP3A But Not CYP2D6 in Oxycodone‐Treated Patients

  2013cites this paper
• Use of analgesics in patients with hepatic impairment

  2013cites this paper
• Population Pharmacokinetics of Oxycodone in Patients With Cancer-Related Pain

  2012cites this paper
• Is saliva a valid substitute for plasma in pharmacokinetic studies of oxycodone and its metabolites in patients with cancer?

  2012cites this paper
• Oxycodone clearance is markedly reduced with advancing age: a population pharmacokinetic study.

  2012cites this paper
• Analgesics in Patients with Hepatic Impairment

  2012cites this paper
• Alternative opioids and administration routes

  2012cites this paper
• Analgesics for Cancer Pain

  2012cites this paper
• Oxycodone/Ibuprofen Combination Tablet

  2012cites this paper
• Oxycodone for the treatment of postoperative pain

  2012cites this paper
• Impact of cachexia on pharmacokinetic disposition of and clinical responses to oxycodone in cancer patients

  2012cites this paper
• [Solutions for the clinical problems of analgesics for cancer pain treatment in Japan].

  2011cites this paper
• Effect of Cytochrome P450 2D6 and 3A Enzyme Inhibition on the Metabolism of Oxycodone

  2011cites this paper
• CYP3A5*3 Affects Plasma Disposition of Noroxycodone and Dose Escalation in Cancer Patients Receiving Oxycodone

  2011cites this paper
• Pharmacokinetic, pharmacodynamic and pharmacogenetic aspects of oxycodone treatment in cancer pain

  2011cites this paper
• Pharmacology of Pediatric Anesthesia

  2011cites this paper
• Oxycodone – first choice medicine for severe cancer pain

  2010cites this paper
• Influences on the pharmacokinetics of oxycodone: a multicentre cross-sectional study in 439 adult cancer patients

  2010cites this paper
• Effects of itraconazole on the pharmacokinetics and pharmacodynamics of intravenously and orally administered oxycodone

  2010cites this paper
• The Role of Cytochrome P450 3A Inducers and Inhibitors in the Metabolism and the Effects of Oxycodone

  2010cites this paper
• A comparison of the respiratory effects of oxycodone versus morphine: a randomised, double‐blind, placebo‐controlled investigation *

  2010cites this paper
• Oksikodoni - jotain uutta, jotain vanhaa

  2010cites this paper
• Strong opioids in cancer pain : clinical and pharmacogenetic factors influencing an individual's response to morphine and oxycodone

  2010cites this paper
• Oxycodone: new ‘old’ drug

  2009cites this paper
• Pharmacology of oxycodone: does it explain why oxycodone has become a bestselling strong opioid?

  2009cites this paper
• Anesthetic and perioperative management of intestinal and multivisceral allograft recipient in nontransplant surgery

  2008cites this paper
• THE PHARMACOLOGY OF OXYCODONE, Studies In Vitro, In Vivo and in Humans

  2008cites this paper
• Oxycodone: a review of its use in the management of pain

  2008cites this paper
• Severe drowsiness caused by oral administration of low dose opioid in a patient with portal stenosis

  2008cites this paper
• Palliation and Liver Failure: Palliative Medications Dosage Guidelines

  2007cites this paper
• Cholestasis and Endogenous Opioids

  2007cites this paper
• Oxicodona en el dolor crónico no oncológico

  2007cites this paper
• Commonsense Oxycodone Prescribing & Safety

  2007cites this paper
• The Pharmacologic Management of Cancer Pain

  2007cites this paper
• Pharmacokinetics and variation in the clearance of oxycodone and hydrocotarnine in patients with cancer pain.

  2007cites this paper
• Pharmacokinetics of morphine and oxycodone following intravenous administration in elderly patients

  2007cites this paper
• Opioid analgesics for persistent pain in the older patient

  2006cites this paper
• Oxycodone Controlled Release in Cancer Pain Management

  2006influential citation
• Oxycodone.

  2005cites this paper
• Pharmacological profile and clinical data in chronic pain management

  2005cites this paper
• Influence of CYP2D6 Genetics on Opioid Kinetics, Metabolism and Response

  2005cites this paper
• The Pharmacokinetics of Oxycodone

  2005cites this paper
• Managing patients with cancer and advanced liver disease

  2005cites this paper
• Oxycodone/Ibuprofen combination tablet: a review of its use in the management of acute pain.

  2005cites this paper
• The pharmacokinetics of oxycodone.

  2005cites this paper
• Ventilatory responses of healthy subjects to intravenous combinations of morphine and oxycodone under imposed hypercapnic and hypoxaemic conditions.

  2005cites this paper
• Normal-release and controlled-release oxycodone: pharmacokinetics, pharmacodynamics, and controversy

  2003influential citation
• Demographics, Assessment and Management of Pain in the Elderly

  2003cites this paper
• Patient-controlled postoperative analgesia: comparison of efficacy, side-effects and safety of various regimens

  2001cites this paper
• Adverse Sedation Events in Pediatrics: Analysis of Medications Used for Sedation

  2000cites this paper
• Morphine or oxycodone in cancer pain?

  2000cites this paper
• Anaesthesia for patients with a transplanted organ

  2000cites this paper
• Pharmacokinetic considerations.

  1999cites this paper